NVO - Novo Nordisk A/S
65.60 +0.64 (0.99%)
Pre-market: 9:22AM EDT
| Previous close | 62.79 |
| Open | 64.17 |
| Bid | 66.02 x 1000 |
| Ask | 65.84 x 800 |
| Day's range | 64.13 - 65.56 |
| 52-week range | 46.92 - 66.02 |
| Volume | 1,608,853 |
| Avg. volume | 2,333,235 |
| Market cap | 151.483B |
| Beta (5Y monthly) | 0.44 |
| PE ratio (TTM) | 26.39 |
| EPS (TTM) | 2.46 |
| Earnings date | N/A |
| Forward dividend & yield | 1.57 (2.41%) |
| Ex-dividend date | 27 Mar 2020 |
| 1y target est | 69.45 |
- Zacks
Pharma Stock Roundup: Q1 Earnings of BMY, NVO, Coronavirus Update From PFE, RHHBY
Novo Nordisk (NVO) and Bristol-Myers (BMY) announce Q1 results. Pfizer (PFE), Roche (RHHBY) and Lilly (LLY) provide update on their coronavirus-related research efforts.
- Simply Wall St.
Novo Nordisk A/S (CPH:NOVO B) Just Beat Earnings: Here's What Analysts Think Will Happen Next
A week ago, Novo Nordisk A/S (CPH:NOVO B) came out with a strong set of quarterly numbers that could potentially lead...
- Zacks
Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates
Novo Nordisk (NVO) beats on Q1 sales and earnings, and maintains outlook amid the coronavirus pandemic.
- Stockopedia
Why quality and momentum matters for Novo Nordisk A/s (CPH:NOVO B)
Quality and momentum are highly prized among investors looking for reliable investment ideas. That's because good quality stocks tend to be resilient, cash-gen8230;
- Motley Fool
Novo Nordisk A/S (NVO) Q1 2020 Earnings Call Transcript
Image source: The Motley Fool. Novo Nordisk A/S (NYSE: NVO)Q1 2020 Earnings CallMay 6, 2020, 7:00 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorHello and welcome to the Q1 2020 Novo Nordisk AS Earnings Conference Call.
- Reuters - UK Focus
GLOBAL MARKETS-World shares mixed amid hopes for business pickup, oil slips
Oil prices slid and world equity markets seesawed on Wednesday as investor hopes for a pickup in business activity were dashed by downbeat economic data and a rise in U.S. crude stockpiles to three-year highs that highlighted low fuel demand. The safe-haven Japanese yen and dollar rose on data showing U.S. private payrolls tumbled by a record 20.2 million workers in April, German industrial orders fell at a record pace in March, and British construction activity fell to an all-time low last month. The dollar index rose 0.299%, with the euro down 0.34% to $1.0801.
- Reuters - UK Focus
GLOBAL MARKETS-World shares mixed amid hopes for business pickup; oil slides
Oil prices slid and world equity markets seesawed on Wednesday as investor hopes for a pickup in business activity were weighed against downbeat economic data and low fuel demand highlighted by a rise in U.S. crude stockpiles to three-year highs. The safe-haven Japanese yen and dollar rose on data showing U.S. private payrolls tumbled to a record 20.2 million in April, German industrial orders fell at a record pace in March and British construction activity fell to an all-time low last month. The Japanese yen strengthened 0.54% versus the greenback at 106.05 per dollar.
- Reuters - UK Focus
GLOBAL MARKETS-World shares mixed amid hopes for business pickup, weak data; oil slides
World equity markets were mixed on Wednesday, with U.S. indexes seesawing amid hopes for a pickup in business activity and as oil prices slumped with demand low after a rise in U.S. crude stockpiles last week to three-year highs. The safe-haven Japanese yen and dollar rose after economic data showed U.S. private payrolls tumbled last month to a record 20.2 million, German industrial orders fell at a record pace in March and UK construction activity crashed to an all-time low in April. The Japanese yen strengthened 0.49% versus the greenback at 106.10 per dollar.
- Reuters - UK Focus
GLOBAL MARKETS-World shares subdued amid weak data; oil resumes gains
Global shares struggled on Wednesday as weak economic data, doubts about the easing of coronavirus lockdowns and simmering U.S.-China tensions cast a pall over markets. Oil prices extended their run of gains, supported by expectations that demand will recover and by a record supply cut from OPEC and other producers.
- Reuters
Novo Nordisk's drug sales boosted by virus-related stockpiling
The world's top maker of diabetes drugs Novo Nordisk <NOVOb.CO> beat profit and sales forecasts in the first quarter and kept its full-year outlook as diabetics stocking up during the coronavirus pandemic led to a surge in demand for its medicines. Novo Nordisk joined U.S. rival Eli Lilly <LLY.N> and other drugmakers in keeping or even raising full-year forecasts as lockdowns to combat the spread of the virus lead to stockpiling of drugs. "COVID-19 related stocking at patient levels significantly impacted our results, however, we are satisfied with the underlying performance," Chief Executive Lars Fruergaard Jorgensen told journalists on Wednesday.
- Zacks
SNY vs. NVO: Which Stock Is the Better Value Option?
SNY vs. NVO: Which Stock Is the Better Value Option?
- Zacks
The Zacks Analyst Blog Highlights: Visa, Novo Nordisk, American Tower, Caterpillar and 3M
The Zacks Analyst Blog Highlights: Visa, Novo Nordisk, American Tower, Caterpillar and 3M
- Zacks
Tracking Q2 and Full-Year 2020 Earnings Estimates
Tracking Q2 and Full-Year 2020 Earnings Estimates
- Reuters - UK Focus
LIVE MARKETS-Will telcos be left behind post Covid, QE?
* HSBC, UBS, Santander: mixed Q1 results Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Thyagaraju Adinarayan (thyagaraju.adinarayan@thomsonreuters.com), Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in Milan.
- Reuters - UK Focus
LIVE MARKETS-Broadcasters hit harder by advertising decline, all focus on Q3
* HSBC, UBS, Santander: mixed Q1 results Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Thyagaraju Adinarayan (thyagaraju.adinarayan@thomsonreuters.com), Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in Milan.
- Reuters - UK Focus
LIVE MARKETS-French mom-and-pop investors in pandemic buying frenzy
* HSBC, UBS, Santander: mixed Q1 results Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Thyagaraju Adinarayan (thyagaraju.adinarayan@thomsonreuters.com), Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in Milan. There's been quite a lot written about pasta and flour stockpiling but piling up stocks during the worst economic and financial crisis in living memory is an interesting one!
- Reuters - UK Focus
LIVE MARKETS-GRANOLAS heavier than the FAAAM'ous five
* HSBC, UBS, Santander: mixed Q1 results Welcome to the home for real-time coverage of European equity markets brought to you by Reuters stocks reporters. You can share your thoughts with Thyagaraju Adinarayan (thyagaraju.adinarayan@thomsonreuters.com), Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in Milan.
- Simply Wall St.
Novo Nordisk (CPH:NOVO B) Could Easily Take On More Debt
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
- Reuters - UK Focus
LIVE MARKETS-Where is the end of the tunnel?
You can share your thoughts with Thyagaraju Adinarayan (thyagaraju.adinarayan@thomsonreuters.com), Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in Milan. HOW CORONAVIRUS COULD HURT GLOBAL TRADE LONG-TERM?
- Zacks
The Zacks Analyst Blog Highlights: Alibaba, Pfizer, S&P Global, Novo Nordisk and Duke Energy
The Zacks Analyst Blog Highlights: Alibaba, Pfizer, S&P Global, Novo Nordisk and Duke Energy
- Reuters - UK Focus
LIVE MARKETS-U.S. stocks to outperform, but credit... Even better!
You can share your thoughts with Thyagaraju Adinarayan (thyagaraju.adinarayan@thomsonreuters.com), Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in Milan. HOW CORONAVIRUS COULD HURT GLOBAL TRADE LONG-TERM?
- Reuters - UK Focus
LIVE MARKETS-The hottest stocks in the world!
You can share your thoughts with Thyagaraju Adinarayan (thyagaraju.adinarayan@thomsonreuters.com), Joice Alves (joice.alves@thomsonreuters.com) and Julien Ponthus (julien.ponthus@thomsonreuters.com) in London and Stefano Rebaudo (stefano.rebaudo@thomsonreuters.com) in Milan. - Tesla's future is pretty uncertain as its outlook mostly depends on Chinese production.
- Zacks
Novo Nordisk's Rybelsus Gets EU Nod for Type II Diabetes
Novo Nordisk (NVO) gains the EU approval for Rybelsus to address adult patients with insufficiently-controlled type II diabetes for improving glycemic control as an adjunct to diet and exercise.
- Zacks
NVS vs. NVO: Which Stock Should Value Investors Buy Now?
NVS vs. NVO: Which Stock Is the Better Value Option?
- Zacks
The Zacks Analyst Blog Highlights: Alphabet, Procter & Gamble, Philip Morris, Novo Nordisk and Tesla
The Zacks Analyst Blog Highlights: Alphabet, Procter & Gamble, Philip Morris, Novo Nordisk and Tesla
